Ventures Fund IV General Partner Llc Flagship serves as Executive at Evelo Biosciences, Inc., where they oversee executive responsibilities. Since joining the company, Ventures Fund IV General Partner Llc Flagship has executed 5 insider transactions totaling $17.0M, demonstrating a bullish approach to their equity position. Their most recent transaction on Jul 11, 2023 involved purchasing 1,082,251 shares valued at $2.5M.
Ventures Fund IV General Partner Llc Flagship currently holds 1,493,241 shares of Evelo Biosciences, Inc. (EVLO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ventures Fund IV General Partner Llc Flagship has been a net buyer of EVLO stock. They have purchased $17.0M and sold $0 worth of shares.
Ventures Fund IV General Partner Llc Flagship's most recent insider trade was on Jul 11, 2023, when they purchased 1,082,251 shares at $2.31 per share.
Get notified when new Form 4 filings are submitted
| $2.31 |
| Discretionary |
| Jul 11, 2023 | EVLO | $2.5M | Purchase | 1,082,251 | $2.31 | Discretionary |
| May 11, 2018 | EVLO | $4.5M | Purchase | 281,250 | $16.00 | Discretionary |
| May 11, 2018 | EVLO | $0 | Conversion | 14,622,143 | $N/A | Discretionary |